Hydrocortisone - Diurnal

Drug Profile

Hydrocortisone - Diurnal

Alternative Names: Alkindi; Chronocort; Hydrocortisone extended release - Diurnal; Infacort

Latest Information Update: 28 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Diurnal
  • Class Anti-inflammatories; Antiallergics; Glucocorticoids; Pregnenediones; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Congenital adrenal hyperplasia; Adrenal insufficiency
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Registered Adrenal insufficiency
  • Phase III Congenital adrenal hyperplasia

Most Recent Events

  • 12 Mar 2018 Diurnal announces intention to seek regulatory approval for Congenital adrenal hyperplasia in European Union by 2020
  • 12 Mar 2018 Diurnal plans a phase II proof-of-concept trial for Adrenal insufficiency by end of 2018
  • 12 Mar 2018 Diurnal plans a phase III trial for Congenital adrenal hyperplasia in mid-2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top